基于T淋巴细胞的免疫反应和肝细胞癌的治疗:专注于TIL和CAR-T细胞
Thikra Majid Muhammed1, Saade Abdalkareem Jasim2, Ahmed Hussein Zwamel3,4,5
1Biology Department, College of Education for Pure Sciences, University of Anbar, Anbar, Iraq.
Naunyn-Schmiedeberg's archives of pharmacology
|March 18, 2025
概括
肝细胞癌 (HCC) 是一种致命的癌症. 瘤透淋巴细胞 (TILs) 在HCC进展和对治疗的反应中发挥关键作用,推动新的基于T细胞的治疗方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因,治疗疗效有限.
- 瘤免疫微环境 (TME) 显著影响HCC的演变,复发和治疗耐药性.
- T细胞,特别是瘤透性淋巴细胞 (TILs),在HCC中表现出复杂的作用,介导着抗瘤和前瘤效应.
研究的目的:
- 检查HCC瘤微环境中的各种TIL亚型的多样性功能和机制.
- 审查目前基于T细胞的免疫疗法对HCC的情况,重点关注TIL和CAR-T细胞.
- 突出TILs在HCC管理中的预后和治疗影响.
主要方法:
- 文献综述和对HCC中TIL现有研究的分析.
- 检查特定T细胞亚型 (Foxp3+,CD8+,CD3+,CD4+) 在HCC进展中的作用.
- 对新兴的基于T细胞的疗法 (包括TIL和CAR-T细胞疗法) 的数据综合.
主要成果:
- TILs是TME的关键组成部分,影响HCC的进展,预后和对治疗的反应.
- 特定的TIL子集,如CD8+T细胞与抗瘤免疫有关,而其他可能促进瘤生长.
- 像TIL和CAR-T细胞治疗这样的新兴疗法在临床前和临床HCC研究中显示出有前途的瘤回归.
结论:
- 了解TIL功能对于改善HCC治疗策略至关重要.
- 基于T细胞的免疫疗法,特别是TIL和CAR-T细胞疗法,是HCC治疗的一个有希望的前沿.
- 对TIL及其治疗应用的进一步研究具有显著的潜力,可以改善HCC患者的治疗结果.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
408
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
相关概念视频
01:27Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
01:27Cytotoxic T Cells-mediated Immune Response
821
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
821
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K